Medical considerations for dental care of patients with alcohol-related liver disease

Journal of the American Dental Association

Volumn 128, Issue 1, 1997, Pages 61-70

  Glick, Michael ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL LIVER DISEASE; BLOOD; CLINICAL PROTOCOL; DENTAL CARE; DRUG DETOXIFICATION; HEMOSTASIS; HUMAN; IMMUNE DEFICIENCY; PATHOPHYSIOLOGY; REVIEW;

ADULT; CLINICAL PROTOCOLS; DENTAL CARE FOR CHRONICALLY ILL; HEMOSTASIS; HUMANS; IMMUNOCOMPROMISED HOST; LIVER DISEASES, ALCOHOLIC; METABOLIC DETOXICATION, DRUG;

EID: 0030641134     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.1997.0027     Document Type: Article

References (58)

1. Midanik LT, Room R. The epidemiology of alcohol consumption. Alcohol Health Res World 1992;16:183-90.
2. Williams GD, Clem DA, Dufour MC. Surveillance report no. 31. Apparent per capita alcohol consumption: national, state and regional trends, 1977-1992. Rockville, Md.: National Institute on Alcohol Abuse and Alcoholism; 1994.
3. Grant BF, Harford TC, Dawson DA, Chou P, Dufour M, Pickering R. Prevalence of DSM-IV alcohol abuse and dependence. United States, 1992. Alcohol Health Res World 1994;18:243-8.
4. Lieber CS. Medical disorders of alcoholism. N Engl J Med 1995;333:1058-65.
5. Highlights from the 1991 National Drug and Alcoholism Treatment Utilization Survey (NDATUS). Rockville, Md.: National Institute on Drug Abuse; 1994.
6. Fe Caces M, Stinson FS, Dufour MC. Surveillance report no. 32. Trends in alcohol related morbidity among short-stay community hospital discharges, United States, 1979-92. Rockville, Md.: National Institute on Alcohol Abuse and Alcoholism; 1994.
7. Angell M, Kassirer JP. Alcohol and other drugs - toward a more rational and consistent policy. N Engl J Med 1994;331:537-9.
8. Dufour C. Chronic liver disease and cirrhosis. In: Everhart J, ed. Digestive diseases in the United States: epidemiology and impact. Washington, D.C.: Superintendent of Documents, Government Printing Office; 1993.
9. Statistical Abstract of the United States: 1995. 115th ed. Washington, D.C.: U.S. Bureau of the Census; 1995.
10. Frezza M, di Padova C, Pozzato G, Terpin M, Baraona E, Lieber CS. High blood alcohol levels in women: the role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med 1990;322:95-9.
11. Harris D, Brunt P. Prognosis of alcoholic liver disease - 100 years on and the need for international standards and guidelines. Alcohol Alcohol 1995;30:591-600.
12. Marbet UA, Bianchi L, Meury U, Stalder GA. Long-term histologic evaluation of the natural history and prognostic factors of alcoholic liver disease. J Hepatol 1987;4:364-72.
13. Anderson P, Cremona A, Paton A, Turner C, Wallace P. The risk of alcohol. Addiction 1993;88:1493-508.
14. Sorensen TI, Orholm M, Bentsen KD, Hoybye G, Eghoje K, Christoffersen P. Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis. Lancet 1984;2:241-4.
15. Lewis CE, Smith E, Kercher C, Spitznagel E. Predictors of mortality in alcoholic men: a 20-year follow-up study. Alcohol Clin Exp Res 1995;19:984-91.
16. Teli MR, Day CP, Burt AD, Bennett AK, James OFW. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 1995;346:987-90.
17. Dufour MC, Stinson FS, Fe Caces M. Trends in cirrhosis morbidity and mortality: United States, 1979-1988. Semin Liv Dis 1993;13:109-25.
18. Goldin R. The pathogenesis of alcoholic liver disease. Int J Exp Pathol 1994;75:71-8.
19. Grunnet N, Kondrup J, Dich J. Effect of ethanol on lipid metabolism in cultured hepatocytes. Biochem J 1985;228:673-81.
20. Lauterburg BH, Liang D, Schwarzenbach FA, Breen KJ. Mitochondrial dysfunction in alcoholic patients as assessed by breath analysis. Hepatology 1993;17;418-22.
21. Flisiak R, Baraona E, Li J, Lieber CS. Effects of ethanol on prostanoid production by liver fat-storing cells. Hepatology 1993;18:153-9.
22. Randall B. Fatty liver and sudden death:a review. Hum Pathol 1980;11:147-53.
23. Parent LJ, Ehrlich R, Matis L, Singer DS. Ethanol: an enhancer of major histocompatibility complex antigen expression. FASEB 1987;1:469-73.
24. el-Newihi HM, Mihas AA. Alcoholic hepatitis recent advances in pathogenesis and therapy. Postgrad Med 1994;96:61-70.
25. Sheron N, Bird G, Koskinas J, et al. Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Hepatology 1993;18:41-6.
26. Mendenhall CL. Alcoholic hepatitis. In: Schiff L, Schiff ER, eds. Diseases of the liver. 6th ed. Philadelphia: Lippincott; 1987:669-85.
27. Friedman SL. The cellular basis of hepatic fibrosis. N Engl J Med 1993;328:1828-35.
28. Moshage H, Casini A, Lieber CS. Acetaldehyde selectively stimulates collagen production in cultured rat liver fat-storing cells but not in hepatocytes. Hepatology 1990; 12:511-8.
29. Li J, Rosman AS, Leo MA, Nagai Y, Lieber CS. Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients, and can serve as a marker of fibrosis. Hepatology 1994;19:1418-23.
30. Halimi C, Deny P, Gotheil C, et al. Pathogenesis of liver cirrhosis in alcoholic patients: histological evidence for hepatitis C virus responsibility. Liver 1991;11:329-33.
31. Aldersley MA, O'Grady JG. Hepatic disorders: features and appropriate management. Drugs 1995;49:83-102.
32. Maddrey WC, Boitnott JK, Bedine MS, Weber FL Jr., Mezey E, White RI Jr. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978;75:193-9.
33. Neuschwander-Tetri BA. Common blood tests for liver disease: which ones are the most useful? Postgrad Med 1995;98:49-63.
34. Whelan G. Biological markers for alcoholism. Aust N Z J Med 1992;22:209-13.
35. Rosman AS, Lieber CS. Diagnostic utility of laboratory tests in alcoholic liver disease. Clin Chem 1994;40:1641-51.
36. George J, Farrell GC. Role of human hepatic cytochromes P450 in drug metabolism and toxicity. Aust N Z J Med 1991;21:356-62.
37. Lieber CS. Hepatic, metabolic and toxic effects of ethanol: 1991 update. Alcohol Clin Exp Res 1991;15:573-92.
38. Whitcomb DC, Block GD. Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 1994;272:1845-50.
39. Seeff LB, Cuccherini BA, Zimmerman HJ, Adler E, Benjamin SB. Acetaminophen hepatotoxicity in alcoholics: a therapeutic misadventure. Ann Intern Med 1986;104:399-404.
40. Howden CW, Birnie GG, Brodie MJ. Drug metabolism in liver disease. Pharmacol Ther 1989;40:439-74.
41. Bass NM, Williams RL. Hepatic function and pharmacokinetics. In: Zakim D, Boyer TD, eds. Hepatology. A textbook of liver disease. 2nd ed. Philadelphia: Saunders; 1990:235-54.
42. Scott-Coombes DM, Whawell SA, Vipond MN, Crnojevic L, Thompson JN. Fibrinolytic activity of ascites caused by alcoholic cirrhosis and peritoneal malignancy. Gut 1993;34:1120-2.
43. Chedid A, Mendenhall CL, Gartside P, et al. Prognostic factors in alcoholic liver disease. Am J Gastroenterol 1991;86:210-6.
44. Pereira LM, Langley PG, Bird GL, Hayllar KM, Tredger JM, Williams R. Coagulation factors V and VIII in relation to severity and outcome in acute alcoholic hepatitis. Alcohol Alcohol 1992;27:55-61.
45. Weibert RT. Oral anticoagulant therapy in patients undergoing dental surgery. Clin Pharmacol 1992;11:857-64.
46. Francis RB Jr., Feinstein DI. Clinical significance of accelerated fibrinolysis in liver disease. Haemostasis 1984;14:460-5.
47. Gram J, Dushka H, Zurborn KH, Bruhn HD. Increased levels of fibrinolysis reaction products (D-dimer) in patients with decompensated alcoholic liver cirrhosis. J Gastroenterol 1991;26:1173-8.
48. Cowan DH. Effect of alcoholism on hemostasis. Semin Hematol 1980;17:137-47.
49. Rubin R, Rand ML. Alcohol and platelet function. Alcohol Clin Exp Res 1994;18(1):105-10.
50. Mikhailidis DP, Jenkins WJ, Barradas MA, Jeremy JY, Dandona P. Platelet function defects in chronic alcoholism. Br Med J 1986;293:715-8.
51. Deykin D, Janson P, McMahon L. Ethanol potentiation of aspirin-induced prolongation of the bleeding time. N Engl J Med 1982;306:852-4.
52. Blake JC, Sprengers D, Grech P, McCormick PA, McIntyre N, Burroughs AK. Bleeding time in patients with hepatic cirrhosis. Br Med J 1990;301:12-5.
53. McGarry GW, Gatehouse S, Vernham G. Idiopathic epistaxis, haemostasis and alcohol. Clin Otolaryngol 1995;20:174-7.
54. Takada A, Takada Y, Urano T. The physiological aspects of fibrinolysis. Thromb Res 1994;76:1-31.
55. Vilde JL, Meyohas MC, Leport C, et al. Association d'une endocardite bactérienne et d'une cirrhose alcoolique chez neuf malades. Ann Med Interne 1986;137:652-5.
56. Rajkovic IA, Williams R. Abnormalities of neutrophil phagocytosis, intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitis. Hepatology 1986;6:252-62.
57. Watson RR, Borgs P, Witte M, et al. Alcohol, immunomodulation, and disease. Alcohol Alcohol 1994;29:131-9.
58. Novacek G, Plachetzky U, Potzi R, et al. Dental and periodontal disease in patients with cirrhosis - role of etiology of liver disease. J Hepatol 1995;22:576-82.